Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—D. Kan.: Hospice provider’s challenge to Medicare enrollment revocation dismissed for lack of jurisdiction
    • BILLING AND CODING—2d Cir.: No Surprises Act does not provide implied private cause of action
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CLINICAL RESEARCH—PROPOSED RULES: FDA proposes to replace animal testing references with broader nonclinical testing terminology
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—NOTICES: DEA revokes Puerto Rico physician’s registration following healthcare fraud exclusion
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—PROPOSED RULES: DEA proposes Schedule I controls for five tryptamine hallucinogens
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • COVERAGE—S.D. Fla.: HHS decision on prior authorization requirement reversed
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • DRUGS AND BIOLOGICS—NOTICES: FDA extends pilot to speed manufacturing readiness for expedited therapies
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ENFORCEMENT ACTIONS—SETTLEMENT AGREEMENTS: OCR settles HIPAA investigation of Ambry Genetics phishing attack
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FRAUD AND ABUSE—N.D. Tex.: Evidence insufficient to show unlawful intent by lab owner to influence physicians
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • GENERAL HEALTH CARE NEWS—GAO REPORTS: HHS only partially implemented defined oversight activities related to cybersecurity for 988 Lifeline in its network agreements
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, DRUGS AND BIOLOGICS—NOTICES: FDA extends pilot to speed manufacturing readiness for expedited therapies, (Sep 24, 2026)

    By WK Editorial Staff

    FDA is expanding support for sponsors developing promising drugs and biologics by continuing a pilot program that provides additional agency engagement to help address manufacturing and quality challenges before marketing application submission.

    The F ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use